21.05.2024 14:04:20 - dpa-AFX: *LILLY'S MIRIKIZUMAB SHOWS POSITIVE RESULTS: OVER HALF OF CROHN'S PATIENTS ACHIEVE REMISSION, EVEN AFTER BIOLOGIC FAILURE

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Eli Lilly & Co 858560 NYSE 878,450 14.06.24 03:00:19 -4,880 -0,55% 878,700 888,000 882,330 878,450

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH